| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $9.47B | $8.92B | $8.02B |
| YoY Revenue Growth % | +6.1% | +11.2% | — |
| Gross Profit | $4.01B | $3.73B | — |
| Gross Margin % | 42.4% | 41.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.71B | $1.07B | $1.24B |
| Operating Margin % | 18.1% | 12.0% | 15.4% |
| Net Income (GAAP) | $1.08B | $617.6M | $762.8M |
| EBITDA (Normalized) | $2.65B | $1.91B | $1.53B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $2.41B | $2.23B | $2.13B |
| Capital Expenditures (CapEx) | $1.18B | $1.06B | $361.0M |
| Free Cash Flow (FCF) | $1.23B | $1.17B | $1.77B |
| FCF Margin % | 13.0% | 13.2% | 22.0% |
| Return on Invested Capital (ROIC %) | 9.7% | 6.4% | 6.5% |
| Cash & Short-Term Equivalents | $46.0M | $62.4M | — |
| Total Debt (Short + Long Term) | $5.80B | $5.38B | $5.86B |
| Total Stockholders' Equity | $8.25B | $7.86B | $12.02B |